Publication: Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients: Difference between revisions
Created page with "{{Publication |Title=Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients |Topic=Ginger (also contains zerumbone) |Author=Ryan, JL; Heckler, CE; Roscoe, JA; Dakhil, SR; Kirshner, J; Flynn, PJ; Hickok, JT; Morrow, GR |Year=2011 |Journal=Support Care Cancer |DOI=https://doi.org/10.1007/s00520-011-1236-3 |Authors Abstract=Purpose Despite the widespread use of antiemetics, nausea continues to be reported by over 70% of pat..." |
No edit summary |
||
Line 1: | Line 1: | ||
{{Publication | {{Publication | ||
|Title=Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients | |Title=Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients | ||
|Topic=Ginger | |Topic=Ginger | ||
|Author=Ryan, JL; Heckler, CE; Roscoe, JA; Dakhil, SR; Kirshner, J; Flynn, PJ; Hickok, JT; Morrow, GR | |Author=Ryan, JL; Heckler, CE; Roscoe, JA; Dakhil, SR; Kirshner, J; Flynn, PJ; Hickok, JT; Morrow, GR | ||
|Year=2011 | |Year=2011 |
Latest revision as of 12:03, 10 September 2024
Reference | |
---|---|
Title | Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients |
Topic | Ginger |
Author | Ryan, JL, Heckler, CE, Roscoe, JA, Dakhil, SR, Kirshner, J, Flynn, PJ, Hickok, JT, Morrow, GR |
Year | 2011 |
Journal | Support Care Cancer |
DOI | https://doi.org/10.1007/s00520-011-1236-3 |
Author's Abstract The abstract and the information and conclusions contained therein were written by the authors of the publication.
Purpose Despite the widespread use of antiemetics, nausea continues to be reported by over 70% of patients receiving chemotherapy.
Methods In this double blind, multicenter trial, we ran- domly assigned 744 cancer patients to four arms: 1) placebo, 2) 0.5 g ginger, 3) 1.0 g ginger, or 4) 1.5 g ginger. Nausea occurrence and severity were assessed at a baseline cycle and the two following cycles during which patients were taking their assigned study medication. All patients received a 5-HT3 receptor antagonist antiemetic on Day 1 of all cycles. Patients took three capsules of ginger (250 mg) or placebo twice daily for 6 days starting 3 days before the first day of chemotherapy. Patients reported the severity of nausea on a 7-point rating scale (“1” = “Not at all Nauseated” and “7” = “Extremely Nauseated”) for Days 1–4 of each cycle. The primary outcomes were to determine the dose and efficacy of ginger at reducing the severity of chemotherapy-induced nausea on Day 1 of chemotherapy. Results A total of 576 patients were included in final analysis (91% female, mean age = 53). Mixed model analyses demonstrated that all doses of ginger significantly reduced acute nausea severity compared to placebo on Day 1 of chemotherapy (p=0.003). The largest reduction in nausea intensity occurred with 0.5 g and 1.0 g of ginger (p=0.017 and p=0.036, respectively). Anticipatory nausea was a key factor in acute chemotherapy-induced nausea (p < 0.0001). Conclusions Ginger supplementation at a daily dose of 0.5 g– 1.0 g significantly aids in reduction of the severity of acute chemotherapy-induced nausea in adult cancer patients. |
This publication is referenced in the following studies: